Jørgen Borrebæk

498 total citations
13 papers, 420 citations indexed

About

Jørgen Borrebæk is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Jørgen Borrebæk has authored 13 papers receiving a total of 420 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Radiology, Nuclear Medicine and Imaging, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in Jørgen Borrebæk's work include Radiopharmaceutical Chemistry and Applications (9 papers), Medical Imaging Techniques and Applications (5 papers) and Lung Cancer Treatments and Mutations (3 papers). Jørgen Borrebæk is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (9 papers), Medical Imaging Techniques and Applications (5 papers) and Lung Cancer Treatments and Mutations (3 papers). Jørgen Borrebæk collaborates with scholars based in Norway and United States. Jørgen Borrebæk's co-authors include Roy H. Larsen, Jostein Dahle, Øyvind S. Bruland, Thora J. Jónasdóttir, Helèn Heyerdahl, Oliver W. Press, Darrell R. Fisher, Nasir Abbas, Dag Rune Olsen and Mikala Skydsgaard and has published in prestigious journals such as Blood, Diabetologia and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Jørgen Borrebæk

13 papers receiving 403 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jørgen Borrebæk Norway 10 354 174 90 68 45 13 420
Roger M. Bjerke Norway 12 448 1.3× 282 1.6× 166 1.8× 54 0.8× 79 1.8× 29 600
Kwon Joong Yong United States 11 360 1.0× 211 1.2× 132 1.5× 51 0.8× 158 3.5× 12 548
Oscar R. Pozzi United States 10 305 0.9× 120 0.7× 62 0.7× 50 0.7× 71 1.6× 17 382
Helèn Heyerdahl Norway 13 275 0.8× 364 2.1× 80 0.9× 45 0.7× 65 1.4× 21 569
Katsuyuki Minegishi Japan 15 351 1.0× 150 0.9× 79 0.9× 104 1.5× 49 1.1× 42 506
M. W. Geerlings Germany 5 234 0.7× 82 0.5× 67 0.7× 24 0.4× 29 0.6× 7 274
Laurence Morandeau Australia 11 222 0.6× 128 0.7× 68 0.8× 18 0.3× 47 1.0× 28 342
Ronald D. Rogus United States 6 362 1.0× 147 0.8× 38 0.4× 209 3.1× 28 0.6× 7 420
Anna Lövqvist Sweden 9 257 0.7× 77 0.4× 49 0.5× 42 0.6× 69 1.5× 14 326
Raffaella M. Schmid Switzerland 9 302 0.9× 166 1.0× 112 1.2× 21 0.3× 88 2.0× 11 429

Countries citing papers authored by Jørgen Borrebæk

Since Specialization
Citations

This map shows the geographic impact of Jørgen Borrebæk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jørgen Borrebæk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jørgen Borrebæk more than expected).

Fields of papers citing papers by Jørgen Borrebæk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jørgen Borrebæk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jørgen Borrebæk. The network helps show where Jørgen Borrebæk may publish in the future.

Co-authorship network of co-authors of Jørgen Borrebæk

This figure shows the co-authorship network connecting the top 25 collaborators of Jørgen Borrebæk. A scholar is included among the top collaborators of Jørgen Borrebæk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jørgen Borrebæk. Jørgen Borrebæk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Heyerdahl, Helèn, et al.. (2011). Treatment of HER2-Expressing Breast Cancer and Ovarian Cancer Cells With Alpha Particle-Emitting 227Th-Trastuzumab. International Journal of Radiation Oncology*Biology*Physics. 79(2). 563–570. 32 indexed citations
2.
Abbas, Nasir, et al.. (2011). Experimental α-particle radioimmunotherapy of breast cancer using 227Th-labeled p-benzyl-DOTA-trastuzumab. EJNMMI Research. 1(1). 18–18. 50 indexed citations
3.
Borrebæk, Jørgen, et al.. (2009). Kostbare erfaringer for vårt døve barn. Tidsskrift for Den norske legeforening. 129(7). 662–663. 2 indexed citations
4.
Dahle, Jostein, Thora J. Jónasdóttir, Helèn Heyerdahl, et al.. (2009). Assessment of long-term radiotoxicity after treatment with the low-dose-rate alpha-particle-emitting radioimmunoconjugate 227Th-rituximab. European Journal of Nuclear Medicine and Molecular Imaging. 37(1). 93–102. 35 indexed citations
5.
Dahle, Jostein, et al.. (2009). In Vitro Cytotoxicity of Low-Dose-Rate Radioimmunotherapy by the Alpha-Emitting Radioimmunoconjugate Thorium-227–DOTA–Rituximab. International Journal of Radiation Oncology*Biology*Physics. 75(3). 886–895. 21 indexed citations
6.
Larsen, Roy H., et al.. (2007). Preparation of TH 227 -Labeled Radioimmunoconjugates, Assessment of Serum Stability and Antigen Binding Ability. Cancer Biotherapy and Radiopharmaceuticals. 22(3). 431–437. 42 indexed citations
7.
Dahle, Jostein, Jørgen Borrebæk, Thora J. Jónasdóttir, et al.. (2007). Targeted cancer therapy with a novel low-dose rate α-emitting radioimmunoconjugate. Blood. 110(6). 2049–2056. 68 indexed citations
8.
Gharagozlian, Sedegheh, Jørgen Borrebæk, Tore Henriksen, et al.. (2006). Effect of hyperglycemic condition on proteoglycan secretion in cultured human endothelial cells. European Journal of Nutrition. 45(7). 369–375. 13 indexed citations
9.
Jónasdóttir, Thora J., Darrell R. Fisher, Jørgen Borrebæk, Øyvind S. Bruland, & Roy H. Larsen. (2006). First in vivo evaluation of liposome-encapsulated 223Ra as a potential alpha-particle-emitting cancer therapeutic agent.. PubMed. 26(4B). 2841–8. 42 indexed citations
10.
Dahle, Jostein, et al.. (2006). Initial evaluation of 227Th-p-benzyl-DOTA-rituximab for low-dose rate α-particle radioimmunotherapy. Nuclear Medicine and Biology. 33(2). 271–279. 51 indexed citations
11.
Larsen, Roy H., Mikala Skydsgaard, Jørgen Borrebæk, et al.. (2006). Radiotoxicity of the alpha-emitting bone-seeker 223Ra injected intravenously into mice: histology, clinical chemistry and hematology.. PubMed. 20(3). 325–31. 55 indexed citations
12.
Jónasdóttir, Thora J., et al.. (2005). Evaluation of Liposomal Radiochemotherapy for Treatment of Cancer. Veterinary and Comparative Oncology. 3(1). 58–59. 1 indexed citations
13.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roger M. Bjerke Breakdown of academic impact, for papers by Kwon Joong Yong Breakdown of academic impact, for papers by Oscar R. Pozzi Breakdown of academic impact, for papers by Helèn Heyerdahl Breakdown of academic impact, for papers by Katsuyuki Minegishi Breakdown of academic impact, for papers by M. W. Geerlings Breakdown of academic impact, for papers by Laurence Morandeau Breakdown of academic impact, for papers by Ronald D. Rogus Breakdown of academic impact, for papers by Anna Lövqvist Breakdown of academic impact, for papers by Raffaella M. Schmid
Rankless by CCL
2026